Online citations, reference lists, and bibliographies.
← Back to Search

Hormonal Influence On Periurethral Vessels In Postmenopausal Incontinent Women Using Doppler Velocimetry Analysis.

Z. I. K. Jármy-Di Bella, M. Girão, V. Di Bella, M. Sartori, J. Szejnfeld, E. C. Baracat, G. R. Lima
Published 2007 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
UNLABELLED The lack of estrogen affects the urinary tract mainly by diminishing vascular, muscular and epithelial trophism, resulting in negative effects on continence in postmenopausal women. OBJECTIVE Study the effect of hormone therapy (estrogen and progesterone) in periurethral vessels detected by Doppler velocimetric analysis using, as parameters, the number of vessels, resistance and pulsatility indexes, as well as the minimum diastolic value. METHODS Thirty-eight postmenopausal women with stress urinary incontinence were randomized into two groups. The first consisted of women receiving 3 months of estrogen therapy previous to 3 months of continuous estrogen and progesterone combined therapy. The second comprised of women receiving 3 months of continuous estrogen and progesterone therapy. Periurethral Doppler velocimetric analysis was done before hormone administration and during treatment in both groups. RESULTS We observed a statistically significant increased number of periurethral vessels during treatment in both groups. There was an increase in value of the mean minimum diastolic value during estrogen and progesterone therapy in Group 2. The resistance indexes diminished in both groups. However, they were not statistically significant. CONCLUSION Hormonal therapy of short duration (3-6 months) had a positive effect on the urethral continence mechanism increasing the number of periurethral vessels either with estrogen alone or combined therapy (estrogen and progesterone).
This paper references
Factors maintaining the intraurethral pressure in women.
T. Rud (1980)
10.1007/s001920070042
Power Doppler of the Urethra in Continent or Incontinent, Pre- and Postmenopausal Women
Z. I. K. Jármy-Di Bella (2000)
10.1007/s003450050057
Study of the female urethra's submucous vascular plexus by color Doppler
J. Beco (1998)
10.1016/0020-7292(95)02358-J
Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens
M. Sartori (1995)
Urogynecology and urodynamics : theory and practice
D. Ostergard (1991)
10.1097/00003081-199006000-00024
Incontinence in the Climacteric
E. Versi (1990)
10.1007/s00192-004-1212-2
Effects of tamoxifen on Doppler velocimetry parameters of periurethral vessels in postmenopausal women
C. A. Faria (2004)
10.1016/S0029-7844(01)01379-5
Bladder Neck Circulation by Doppler Ultrasonography in Postmenopausal Women With Urinary Stress Incontinence
E. Tsai (2001)
10.1046/j.1532-5415.2001.49160.x
Effects of Oral Estrogen and Progestin on the Lower Urinary Tract Among Female Nursing Home Residents
J. Ouslander (2001)
10.1159/000299141
Effect of estradiol and estriol treatment on vaginal estrogen receptors in the ovariectomized rabbit.
S. Batra (1984)
10.1002/14651858.CD001405
Oestrogens for urinary incontinence in women.
B. Moehrer (2003)
10.1016/S0022-5347(01)64919-X
Female Urology, 2nd ed.
A. Burnett (1997)
10.3109/00016347709155025
Intra‐Urethral and Intra‐Vesical Pressure in Continent Women
A. Öbrink (1977)
10.1016/S0146-0005(00)80059-2
An update on estrogen receptors.
J. Gustafsson (2000)
10.1016/S0022-5347(17)45338-9
Increases in blood flow of the female rabbit urethra following low dose estrogens.
S. Batra (1986)
Dopplervelocimetria dos vasos peri-uretrais de mulheres na pós-menopausa com incontinência urinaria de esforço, antes e durante o uso de estrogenioterapia intravaginal
Sílvia Aiko Kobata (2002)
10.1159/000280026
Estrogenic sensitivity of alpha-receptors in the urethra musculature.
F. Schreiter (1976)
10.1111/J.1748-1716.1985.TB07577.X
Effect of oestrogen and progesterone on the blood flow in the lower urinary tract of the rabbit.
S. Batra (1985)
10.1007/PL00004024
Effect of Estrogen–Progestogen Hormonal Replacement Therapy on Periurethral and Bladder Vessels
R. M. Endo (2000)
10.1016/0002-9378(53)90437-2
The corpus spongeosum of the urethra: its possible role in urinary control and stress incontinence in women.
S. G. Berkow (1953)
Estrogen Therapy in the Management of Urinary Incontinence in Postmenopausal Women: A Meta-Analysis. First Report of the Hormones and Urogenital Therapy Committee
J. A. Fantl (1994)
10.1007/s001920170046
Doppler Velocimetry Parameters of Periurethral Vessels in Postmenopausal Incontinent Women Receiving Estrogen Replacement
M. Girão (2001)
[Efficacy of estrogen therapy in urinary incontinence. A meta-analytic study].
M. A. Zullo (1998)



This paper is referenced by
10.3109/13697137.2010.508542
Sexual steroids in urogynecology
M. Sartori (2011)
Paediatric urolithiasis in central coast region of Tunisia: changes in stone composition according to age and gender.
A. Alaya (2010)
10.1016/j.maturitas.2012.10.005
Menopause, hormone treatment and urinary incontinence at midlife.
G. Legendre (2013)
10.5489/CUAJ.1049
Should hormone replacement therapy be used in postmenopausal women for voiding dysfunction?
L. Stothers (2009)
10.1016/j.ejogrb.2020.04.017
The impact of breastfeeding on pelvic floor recovery from pregnancy and labor.
Shoham Iris (2020)
The menopause is a universal physiological event related with the drop in ovarian hormone 53 secretions (œstrogens and progestin) that occurs as the stock of ovarian follicules
G. Legendre (2013)
10.1590/S1516-31802012000100002
Efficacy of pelvic floor muscle training and hypopressive exercises for treating pelvic organ prolapse in women: randomized controlled trial.
B. Bernardes (2012)
10.1016/J.JCOL.2018.03.005
Establishing the normal ranges of female and male anal canal and rectal wall vascularity with color Doppler anorectal ultrasonography
S. Murad-Regadas (2018)
Efeito da terapêutica com estrogéneos na incontinência urinária
Gisela Lage (2013)
10.1016/j.purol.2013.03.012
[Role of estrogens in lower urinary tract physiology and physiopathology].
X. Gamé (2013)
Title 1 Menopause, Hormone Treatment and Urinary Incontinence at Midlife 2 3 Authors 4
Guillaume Legendre ()
10.1016/J.PUROL.2013.03.012
Rôle des estrogènes sur la physiologie et la physiopathologie du bas appareil urinaire
X. Gamé (2013)
10.1002/ar.23795
Regional Structural and Functional Specializations in the Urethra of the Female Rat: Evidence for Complex Physiological Control Systems.
Monica Eggermont (2018)
10.3109/13697137.2015.1132199
The role of local estrogen therapy in the management of pelvic floor disorders
T. Tzur (2016)
10.1016/j.jphys.2018.05.002
Pelvic floor muscle training increases pelvic floor muscle strength more in post-menopausal women who are not using hormone therapy than in women who are using hormone therapy: a randomised trial.
Flávia Ignácio Antônio (2018)
10.1016/j.maturitas.2008.07.015
Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Dopplervelocimetry analysis.
S. Kobata (2008)
10.1016/j.maturitas.2009.01.003
Isoflavone regulates vascular endothelial growth factor expression in urinary tract of castrated rats.
M. D. D. Sampaio (2009)
Semantic Scholar Logo Some data provided by SemanticScholar